Healthcare and Life Science
o2h technology announces the launch of the third edition of the Tech Kickstarter Competition
Cambridge, UK: o2h technology, a business vertical of the o2h group, is thrilled to announce the launch of the third edition of its Tech Kickstarter Competition. This initiative is designed to support innovative seed and early stage companies by helping them meet their MVP, ...
Common diabetes drug slows growth of normal cells carrying cancer mutation
A common diabetes medication, metformin, slows the growth of precancerous cells in the oesophagus while some metabolic conditions accelerate it, suggests a new study. ...
Team’s hip replacement surgery invention is set to be world first
Technology which is the first of its kind in the world and could transform the future of hip replacement surgery is being pioneered by a team of experts in Cambridge. ...
Owlstone Medical celebrates success at SME Cambridgeshire Business Awards
It was a double success as the Owlstone Medical team scooped two awards. The company won Website of the Year for its OMED Health website and silver for Employer of the Year. ...
Nxera’s Partner Cancer Research UK to Present on Phase 1/2a Clinical Trial with Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera’s novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies Cancer Research UK’s Centre for Drug Development is sponsoring and managing the ongoing Phase 1/2a clinical trial o...
New therapy that targets and destroys tau tangles is a promising future Alzheimer’s disease treatment
Medical Research Council media release.
Cambridge Enterprise appoints new Chief Executive
Dr Jim Glasheen has been appointed as Chief Executive of Cambridge Enterprise, the innovation arm of the University of Cambridge. Dr Glasheen will assume his post later in 2024. ...
New state-of-the-art radiotherapy equipment benefiting patients in the East
Cancer patients undergoing treatment at Norfolk and Norwich University Hospital’s NHS Foundation Trust (NNUH) and Cambridge University Hospitals NHS Foundation Trust (CUH) are benefiting from a new type of radiotherapy which reduces treatment time whilst increasing accuracy and patient ...
Breast and ovarian cancer newly linked to thousands of gene variants
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for better risk assessment and more personalised care. ...